Walleye Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.4K | Buy |
5,243
+630
| +14% | +$5.34K | ﹤0.01% | 1654 |
|
|
2025
Q1 | $37.1K | Buy |
+4,613
| New | +$37.1K | ﹤0.01% | 1658 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2102 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2483 |
|
|
2024
Q2 | – | Sell |
-1,279
| Closed | -$6.41K | – | 2648 |
|
|
2024
Q1 | $6.41K | Buy |
+1,279
| New | +$6.41K | ﹤0.01% | 2403 |
|
|
2023
Q1 | – | Sell |
-82,245
| Closed | -$355K | – | 2134 |
|
|
2022
Q4 | $355K | Sell |
82,245
-214,463
| -72% | -$926K | 0.01% | 1130 |
|
|
2022
Q3 | $2.23M | Buy |
+296,708
| New | +$2.23M | 0.04% | 409 |
|
|
2022
Q2 | – | Sell |
-34,586
| Closed | -$428K | – | 2295 |
|
|
2022
Q1 | $428K | Buy |
+34,586
| New | +$428K | 0.01% | 1057 |
|
|
2020
Q1 | – | Sell |
-68,570
| Closed | -$1.39M | – | 540 |
|
|
2019
Q4 | $1.39M | Buy |
+68,570
| New | +$1.39M | 0.09% | 80 |
|